pentobarbital will decrease the extent or result of cobimetinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration. Potent or reasonable CYP3A inducers could decrease cobimetinib systemic publicity by >80% and lower its efficacy.In Australia, Nembutal and secobarbital can be used for animals, b